Patrick Y. Yang Acquires 10,000 Shares of Codexis Inc. (CDXS) Stock
Codexis Inc. (NASDAQ:CDXS) Director Patrick Y. Yang purchased 10,000 shares of the stock in a transaction on Tuesday, November 15th. The stock was acquired at an average price of $4.83 per share, with a total value of $48,300.00. Following the acquisition, the director now directly owns 320,340 shares in the company, valued at $1,547,242.20. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.
Codexis Inc. (NASDAQ:CDXS) traded down 1.02% during mid-day trading on Friday, reaching $4.85. The company’s stock had a trading volume of 30,394 shares. The firm has a 50-day moving average of $4.57 and a 200 day moving average of $4.17. The firm’s market capitalization is $199.92 million. Codexis Inc. has a 1-year low of $2.93 and a 1-year high of $5.25.
Codexis (NASDAQ:CDXS) last announced its quarterly earnings data on Tuesday, November 8th. The company reported $0.09 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.14) by $0.23. The business earned $14.90 million during the quarter, compared to analyst estimates of $7.41 million. Codexis had a negative return on equity of 5.25% and a negative net margin of 10.60%. The company’s revenue was down 14.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.19 earnings per share. Equities analysts expect that Codexis Inc. will post ($0.20) earnings per share for the current year.
Separately, Zacks Investment Research cut Codexis from a “buy” rating to a “hold” rating in a report on Wednesday, November 9th.
Hedge funds have recently made changes to their positions in the stock. California State Teachers Retirement System raised its stake in shares of Codexis by 1.0% in the third quarter. California State Teachers Retirement System now owns 70,898 shares of the company’s stock valued at $315,000 after buying an additional 700 shares during the period. Rhumbline Advisers raised its stake in shares of Codexis by 16.7% in the third quarter. Rhumbline Advisers now owns 35,558 shares of the company’s stock valued at $158,000 after buying an additional 5,100 shares during the period. Northern Trust Corp raised its stake in shares of Codexis by 3.1% in the third quarter. Northern Trust Corp now owns 357,821 shares of the company’s stock valued at $1,589,000 after buying an additional 10,753 shares during the period. Oxford Asset Management raised its stake in shares of Codexis by 15.1% in the second quarter. Oxford Asset Management now owns 103,404 shares of the company’s stock valued at $417,000 after buying an additional 13,589 shares during the period. Finally, Nantahala Capital Management LLC raised its stake in shares of Codexis by 0.3% in the third quarter. Nantahala Capital Management LLC now owns 5,561,082 shares of the company’s stock valued at $24,691,000 after buying an additional 15,539 shares during the period. Institutional investors and hedge funds own 57.10% of the company’s stock.
Codexis Company Profile
Codexis, Inc is a developer of biocatalysts for the pharmaceutical and fine chemicals markets. The Company’s CodeEvolver protein engineering technology platform, which introduces genetic mutations into genes in order to give rise to changes in the enzymes that they produce, overcomes many of the limitations, allowing customers to evolve and optimize biocatalysts to perform specific and desired chemical reactions at commercial scale.
Receive News & Stock Ratings for Codexis Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Codexis Inc. and related stocks with our FREE daily email newsletter.